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Introduction 
• Arterial hypertension (AH) is a serious, debilitating disease, that 
is not only medical but also social and economic problem 
worldwide:  
– about 45% of adults aged from 25 years old have high blood 
pressure,  
– 74.3% are aware about the disease,  
– just 43% are treated,  
– efficacy of the treatment is only 13%. 
• Maintaining achieved target blood pressure (BP) levels in 
patients with AH continues to represent an urgent problem.  
• Key point of AH is an imbalance of regulatory systems. 
• Low efficiency of pharmacotherapy boosted searching for non-
drug methods. 
• Promising tool of adjunctive therapy in patients with AH can be 
biofeedback (BFB) in the closed loop of paced breathing under 
the control of heart rate variability (HRV) parameters. 
 
• Biofeedback is the process of gaining greater awareness of 
many physiological functions primarily using instruments that 
provide information on the activity of those same systems, with 
a goal of being able to manipulate them at will. 
• HRV is one of the first systems that responds to subtle 
environmental influences, which makes it a convenient loop of 
biofeedback. 
• Paced breathing is a method of influence on the state of the 
regulatory systems of the body 
• comfortable: easy to implement (patient need to breathe with 
a certain specified frequency); 
• flexible: at the respective frequencies it can selectively 
affect specific links of the HRV spectrum. 
 
Introduction 
• The purpose of the research is to study the effectiveness of 
biofeedback in a closed loop of heart rate variability and paced 
breathing in patients with arterial hypertension in real clinical 
practice. 
Our patients 
Patient 1: male, 64 y/o, retired, 
lives in the city, admitted to the 
hospital in November 2014. 
Patient 2: male, 60 y/o, retired, 
lives in the city, admitted to the 
hospital in October 2014. 
Permission to publish photos of patients was obtained. 
Complaints on admittance 
periodical increase of BP up to 
150/100 mm Hg, usually in the 
morning, followed by headache in 
occipital area and/or dizziness. 
episodic increase of BP up to 
150/90 mm Hg, usually in the 
morning, which followed by 
headache in frontal and temporal 
areas. 
Anamnesis morbi 
Arterial hypertension since 2000 
with maximum BP 155/100 mm Hg.  
Usual BP 120-130/70-80 mm Hg.  
Multiple hospitalizations and 
treatment in outpatient clinic.  
Previous hospitalization in CCH 
“UZ” in November 2013, after 
discharge ignored prescribed 
treatment.  
Current hospitalization due to 
complaints described above. 
Arterial hypertension since 1995 
with maximum BP 155/105 mm 
Hg.  
Usual BP 120/70 mm Hg.  
Multiple hospitalizations and 
treatment in outpatient clinic.  
Previous hospitalization in CCH 
“UZ” in January 2014, after 
discharge regularly took Arifon 
2,5 mg in the morning.  
Current hospitalization due to 
same complaints. 
Anamnesis vitae 
Appendectomy in young age.  
Tuberculosis, diabetes mellitus, 
STD, viral hepatitis, rheumatism, 
psychiatric diseases in the 
anamnesis denies.  
No pernicious habits.  
No alcohol abuse.  
Heredity is uncomplicated.  
No allergic reactions in the past. 
Right wrist joint fracture in 1983.  
Tuberculosis, diabetes mellitus, 
STD, viral hepatitis, rheumatism, 
psychiatric diseases in the 
anamnesis denies.  
No pernicious habits.  
No alcohol abuse.  
Heredity is uncomplicated.  
No allergic reactions in the past. 
Status presence objectivus 
Patients overall condition is satisfactory, consciousness is clear, 
position is active.  
Ectomorph body type.  
Growth 175 cm, weight 68 kg, waist 90 cm, BMI 22,0 kg/m2.  
Skin and visible mucous are pale-pink, clear.  
Peripheral lymph nodes are not enlarged.  
Thyroid gland can’t be palpated.  
Skeletal-muscular system without features.  
Respiratory system: clear lung sound during percussion, vesicular 
breathing during auscultation without additional sounds. 
CVS: heart rate is rhythmic, tones are muffled, accent of the S2 on 
aorta. HR = pulse = 65 bpm. BP 150/100 mm Hg. 
Abdomen is normal in size, soft and painless during palpation.  
Liver under the edge of ribs arch, painless.  
No peripheral edema. 
Status presence objectivus 
Patients overall condition is satisfactory, consciousness is clear, 
position is active.  
Ectomorphic body type.  
Growth 170 cm, weight 60 kg, waist 84 cm, BMI 21,0 kg/m2.  
Skin and visible mucous are pale-pink, clear.  
Peripheral lymph nodes are not enlarged.  
Thyroid gland can’t be palpated.  
Skeletal-muscular system without features.  
Respiratory system: clear lung sound during percussion, vesicular 
breathing during auscultation without additional sounds. 
CVS: heart rate is rhythmic, tones are muffled, accent of the S2 on 
aorta. HR = pulse = 68 bpm. BP 150/90 mm Hg. 
Abdomen is normal in size, soft and painless during palpation.  
Liver under the edge of ribs arch, painless.  
No peripheral edema. 
Investigation plan in the hospital 
• CBC 
• Clinic urine analysis. 
• Biochemical blood test (bilirubin, ALT, AST, glucose, creatinine, Na, 
K) 
• Lipid profile 
• Chest x-ray 
• ECG 
• Heart ultrasound with Doppler 
• Kidneys ultrasound with Doppler 
• Ophthalmologist consultation. 
Investigation results 
CBC 
Indexes 
Result  
(patient 1) 
Result  
(patient 2) 
Norm 
(SI units) 
Hb 148 g/l 141 g/l 130-160 g/l 
Erythrocytes 4,35 Т/l 4,13 Т/l 4-5 Т/l 
Platelet cell 283 g/l 235 g/l 180-320 g/L 
Leucocytes 5,2 g/l 6,8 g/l 4-9 g/l 
ESR 2 mm/h 4 mm/h 
1-10 mm/h by 
Panchenkov 
Neutrophils: 
myelocytes 
- - - 
band 1,0 % - 1,0-6,0 % 
segmented 66 % 3,0 % 47-72 % 
Eosinophils 3 % 66 % 0,5-5,0 % 
Basophils -   0-1 % 
Lymphocytes 21 % 1 % 19-37 % 
Monocytes 9 % - 3-11 % 
Ht 41,5 % 26 % 40-48 % 
Conclusion: indexes are in normal range. 
Investigation results 
Conclusion: indexes are in normal range. 
Urine test 
Indexes 
Result 
(patient 1) 
Result 
(patient 2) 
Norm 
(SI units) 
Volume 120,0 ml 110,0 ml ml  
Color yellow 
light-
yellow 
light-
yellow 
Feculence  weak weak weak 
Density 1,020 1,017 1,015-1,025 
рН 5,5 5,0 5,0-7,0 
Protein traces - traces 
Glucose - - - 
Mucus 
small 
amount 
small 
amount 
small 
amount 
Investigation results 
Conclusion: indexes are in normal range. 
Biochemical blood test 
Indexes 
Result  
(patient 1) 
Result  
(patient 2) 
Norm 
(SI units) 
Glucose 5,1 4,6 3,9-6,4 mmol/l 
Creatinine 88,0 93,0 80-115 mkmoll/l 
Bilirubin:  
total 
18,9 15,0 1,7-21 mkmoll/l 
conjugated 2,5 2,0 less 3,4 mkmoll/l 
unconjugated 16,4 13,4 less 17,6 mkmoll/l  
ALT 23 21 less 42 U/L 
AST 20 27 less 35 U/L 
Na 140 138 136-145 mmol/l 
K 4,8 5,0 3.6-5.5 mmol/l 
Investigation results 
Conclusion: indexes are in normal range. 
Lipid profile 
Indexes 
Result  
(patient 1) 
Result  
(patient 2) 
Norm 
(SI units) 
Total 
cholesterol 
2,97 4,0 до 5,2 mmol/l 
VLDL 0,4635 0,349 до 1,0 mmol/l 
LDL 1,4265 1,654 до 3,5 mmol/l 
HDL 1,08 1,0 
больше 0,9 
mmol/l 
Triglycerides 1,03 1,77 до 2,3 mmol/l 
Atherogenic 
factor 
1,75 3,0 до 3,0 
Investigation results 
Chest x-ray: Focal or infiltrative changes in lung are not detected. 
Roots are structured, not extended. Diaphragm is clearly outlined. 
Heart is slightly extended to the left. Aorta without features. 
 
ECG: sinus rhythm, regular, HR 61 bpm. Hypertrophy of myocardium of 
left ventricle by wave’s ratio criterion.  
 
Heart ultrasound with Doppler: Hypertrophy of myocardium of left 
ventricle (LV posterior wall thickness: 12 mm, interventricular septum: 
11,8 mm), systolic function is preserved (EF = 61%) 
 
Kidneys ultrasound with Doppler: Incomplete doubling of left kidney, 
micro urolithiasis.  
 
Ophthalmologist consultation: Angiopathy of retinal vessels of both 
eyes. 
Investigation results 
Chest x-ray: Focal or infiltrative changes in lung are not detected. 
Roots are structured, not extended. Diaphragm is clearly outlined. 
Heart is slightly extended to the left. Aorta without features. 
 
ECG: sinus rhythm, regular, HR 64 bpm. Hypertrophy of myocardium of 
left ventricle by wave’s ratio criterion.  
 
Heart ultrasound with Doppler: Hypertrophy of myocardium of left 
ventricle (LV posterior wall thickness: 12,3 mm, interventricular 
septum: 12,0 mm), systolic function is preserved (EF = 64%) 
 
Kidneys ultrasound with Doppler: Micro urolithiasis.  
 
Ophthalmologist consultation: Angiopathy of retinal vessels of both 
eyes. 
Diagnosis 
Classification of AH depends of the stage 
(recommendations of Ukrainian Heart Association, 2008) 
Stage Degree of target organ damage 
I Objective changes in the target organs are absent 
II 
Presence of objective evidence in target-organs without 
symptoms or dysfunctions: 
• left ventricular hypertrophy (on ECG, ultrasound, Ro);  
• generalized narrowing of the retinal arteries;  
• microalbuminuria and/or increasing of creatinine 
concentration; 
• carotid artery disease  
III 
Presence of objective evidence in target-organs with symptoms or dysfunctions: 
• heart: myocardial infarction, heart failure, II A - III stage;  
• brain: stroke, transient ischemic attack, acute hypertensive encephalopathy, 
vascular dementia;  
• eye-ground: hemorrhage and retinal exudates with/without papilledema of optic 
nerve;  
• kidney: creatinine concentration in plasma > 133 mmol/l  
Diagnosis 
Classification of AH depends of the degree 
(ESH/ESC Guidelines for the management of arterial hypertension, 2013) 
Category 
Systolic blood pressure  
(mm Hg) 
Diastolic blood pressure  
(mm Hg)  
Optimal blood pressure < 120 < 80  
Normal blood pressure < 130 < 85  
Normal blood pressure < 130 < 85  
Mild hypertension  
(1 degree) 
140-159 90-99  
Moderate hypertension  
(2 degree)  
160-179 100-109  
Severe hypertension  
(3 degree) 
> 180 > 100  
Isolation systolic hypertension > 140 > 90  
Diagnosis 
Risk stratification 
(ESH/ESC Guidelines for the management of arterial hypertension, 2013) 
Clinical diagnosis 
Arterial hypertension II stage 1 degree, HF 0 stage, 
moderate additional risk 
Arterial hypertension II stage 1 degree, HF 0 stage, 
moderate additional risk 
Treatment 
Lifestyle modification: control of body weight, diet, 
regular exercises. 
Drugs therapy: perindopril 5 mg 1 time per day in the 
evening, aspirin-cardio 100 mg in the evening. 
Non-drug therapy:  
 for patient 1 – 10 biofeedback sessions in the loop 
of paced  breathing under the control of heart rate 
variability parameters; 
 for patient 2 – 10 biofeedback pseudosessions 
under the control of heart rate variability parameters. 
 
 
Devices: 
• computer diagnostic complex ”CardioLab 2009” (“KhAI-Medica”); 
• module “Biofeedback” (programmatically connected aural-visual 
breathing metronome and algorithm of HRV parameters 
estimation). 
Methods of research 
Methods of research 
Efficacy of biofeedback was evaluated by comparing the values of: 
• systolic, diastolic and pulse blood pressure (SBP, DBP and PP, 
respectively); 
• BQI integral index – parameter that reflects all qualitative changes 
of biofeedback process: 
• optimality (O) – estimation of farness of regulatory systems 
from optimal state during whole period of session; 
• sensitivity (S) – estimation of receptivity of regulatory systems 
to paced breathing; 
• effectiveness (E) – estimation of approaching range of HRV 
parameters to optimal physiological state during execution of 
optimal bioreverse control algorithm. 
 
Statistical analysis of the results for each subject was carried out using Microsoft Excel 
computer software.  
The significance of differences between groups on the stages of the study was 
determined using the U-Mann-Whitney test.  
The significance of differences between the values of the indices at given stage and 
before treatment was determined using the T-Wilcoxon test. 
Results 
Dynamics of SBP, DBP and PP during 10 days of stationary 
treatment in both patients 
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Notes: * - P < 0.05 at the sessions against initial values; ‡ - P < 0.05 between patients at the 
current session. 
During the same treatment in both patients systemic biofeedback 
implementation contributed to lower values aforementioned 
indices. 
Results 
BQI index dynamics in both patients during 10 sessions 
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Notes: * - P < 0.05 at the sessions against initial values; ‡ - P < 0.05 between patients at the 
current session. 
Systematic biofeedback sessions in patient 1 contributed natural 
approximation of regulation to the optimal level, whereas in patient 
2 it index fluctuated within suboptimal level without reaching the 
target level. 
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Conclusions 
• Biofeedback in a closed loop of heart rate variability and paced 
breathing allow to optimize the regulatory systems condition of 
the body in patients with arterial hypertension. 
 
•  Combination of biofeedback sessions and drug treatment is 
significantly superior in effectiveness of the isolated 
pharmacological therapy. 
 
•  The effectiveness of biofeedback in a closed loop of heart rate 
variability and paced breathing allows us to recommend it as a 
component of complex therapy for patients with arterial 
hypertension. 
Thank you for your attention!!! 
